Eli Lilly

More data supports Jardiance lead in cardiovascular battle

September 14, 2017

Cardioprotective effect occurred in patients independently of blood sugar control

More data supports Jardiance lead in cardiovascular battle

https://pharmaphorum.com/news/bililly-produce-data-supporting-diabetes-drug-jardiance/

Novo’s semaglutide outperforms Lilly GLP-1 rival

August 17, 2017

If approved semaglutide could become set the standard for GLP-1 therapy

Novo’s semaglutide outperforms Lilly GLP-1 rival

https://pharmaphorum.com/news/semaglutide-outperforms-lilly-glp-1-rival/

RA pill setback spoils Lilly’s growth story

July 25, 2017

Eli Lilly has posted a strong 8% increase in sales for the second quarter, led by growth of

RA pill setback spoils Lilly’s growth story

https://pharmaphorum.com/news/ra-pill-setback-spoils-lillys-growth-story/

Surge of Alzheimer’s drugs in pipeline gives hope of progress

July 18, 2017

Authors “optimistic” despite issues with front runners from AB Science and Otsuka

Surge of Alzheimer’s drugs in pipeline gives hope of progress

https://pharmaphorum.com/news/35-alzheimers-drugs-hit-market-2022-report/

J&J’s psoriasis drug faces crowded market after US approval

July 14, 2017

J&J taking on next gen drugs from Novartis, Eli Lilly, and Valeant.

J&J’s psoriasis drug faces crowded market after US approval

https://pharmaphorum.com/news/jj-psoriasis-us-approval/

Alder shares slump despite migraine success

June 28, 2017

Investors concerned over strong placebo effect

Alder shares slump despite migraine success

https://pharmaphorum.com/news/alder-shares-slump-despite-migraine-success/

FDA fast-tracks Lilly/Pfizer pain drug amid opioid crisis

June 15, 2017

Companies hope tanezumab offers alternative to opioids

FDA fast-tracks Lilly/Pfizer pain drug amid opioid crisis

https://pharmaphorum.com/news/lillypfizer-pain-drug-gets-fda-fast-review/

Lilly’s sarcoma drug Lartruvo recommended via Cancer Drugs Fund

June 13, 2017

Lilly’s drug will be re-appraised in 2020

Lilly’s sarcoma drug Lartruvo recommended via Cancer Drugs Fund

https://pharmaphorum.com/news/lillys-sarcoma-drug-lartruvo-recommended-via-cancer-drugs-fund/

Teva plans migraine drug filing later this year

June 8, 2017

Blockbuster hopeful could launch next year if approved.

Teva plans migraine drug filing later this year

https://pharmaphorum.com/news/teva-plans-migraine-drug-filing-later-year/

1 2 3 4 5 >»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Eli Lilly

More data supports Jardiance lead in cardiovascular battle

Novo’s semaglutide outperforms Lilly GLP-1 rival

RA pill setback spoils Lilly’s growth story

Surge of Alzheimer’s drugs in pipeline gives hope of progress

J&J’s psoriasis drug faces crowded market after US approval

Alder shares slump despite migraine success

FDA fast-tracks Lilly/Pfizer pain drug amid opioid crisis

Lilly’s sarcoma drug Lartruvo recommended via Cancer Drugs Fund

Teva plans migraine drug filing later this year

CDD for Biologics Summit 2017

Neoantigen Summit 2017

ICI Summit Europe 2017

6th International GMP, GCP & Quality Control Summit

3rd Annual Pre-Filled Syringes Summit

Inhalation and Respiratory Drug Products Summit

Search

Advanced Search

Trending

Eli Lilly